No immediate plans for further stake sales or Biocon Biologics IPO: CEO Siddharth Mittal

Siddharth Mittal, CEO & MD of Biocon says the company will evaluate Biologics IPO after committee review; current focus is on servicing private equity and structured obligations.

Leave a Reply

Your email address will not be published. Required fields are marked *